Antisense modulation of PI3 kinase p110 beta expression

Details Antisense modulation of PI3 kinase p110 beta expression Antisense modulation of PI3 kinase p110 beta expression

1999-09-09

2000-10-17

Elliott, George C.

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Method of regulating cell metabolism or physiology

435325, 435366, 435 6, 435 911, 536 231, 536 2431, 536 2433, 536 245, C07H 2104, C12N 1500, C12Q 168

Patent

active

061330329

ABSTRACT:
Antisense compounds, compositions and methods are provided for modulating the expression of PI3 kinase p110 beta. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PI3 kinase p110 beta. Methods of using these compounds for modulation of PI3 kinase p110 beta expression and for treatment of diseases associated with expression of PI3 kinase p110 beta are provided.

REFERENCES:
patent: 5776689 (1998-07-01), Karin et al.
patent: 5801154 (1998-09-01), Baracchini et al.
Branch TIBS 23, pp. 45-50, Feb. 1998.
Crooke "Antisense Research and Application" pp. 1-50, Springer, New York, Jul. 7, 1998.
Agrawal TIB Tech vol. 14 pp. 376-387, Oct. 1996.
Milner et al. Nature Biotechnology vol. 15 Jun. 1997 pp. 537-541, Jun. 1997.
James, Antiviral Chemistry and Chemotherapy 2(4), 191-214, 1991.
Deora et al., A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3'-kinase to Ras by redox stress, J. Biol. Chem., 1998, 273:29923-29928.
Fry, Structure, regulation and function of phosphoinositide 3-kinases, Biochim. Biophys. Acta., 1994, 1226:237-268.
Graness et al., A novel mitogenic signaling pathway of bradykinin in the human colon carcinoma cell line SW-480 involves sequential activation of a Gq/11 protein, phosphatidylinositol 3-kinase beta, and protein kinase Cepsilon, J. Biol. Chem., 1998, 273:32016-32022.
Hu et al., Cloning of a novel, ubiquitously expressed human phosphatidylinositol 3- kinase and identification of its binding site on p85, Mol. Cell. Biol., 1993, 13:7677-7688.
Molz et al., Cpk is a novel class of Drosophila PtdIns 3-kinase containing a C2 domain, J. Biol. Chem., 1996, 271:13892-13899.
Schu et al., Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting, Science, 1993, 260:88-91.
Stirdivant et al., Cloning and mutagenesis of the p110 alpha subunit of human phosphoinositide 3'-hydroxykinase, Bioorg. Med. Chem., 1997, 5:65-74.
Stoyanov et al., Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase, Science, 1995, 269:690-693.
Ui et al., Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase, Trends Biochem. Sci., 1995, 20:303-307.
Vanhaesebroeck et al., P110delta, a novel phosphoinositide 3-kinase in leukocytes, Proc. Natl. Acad. Sci. U. S. A., 1997, 94:4330-4335.
Vlahos et al., A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4- morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002), J. Biol. Chem., 1994, 269:5241-5248.
Woscholski et al., A comparison of demethoxyviridin and wortmannin as inhibitors of phosphatidylinositol 3-kinase, FEBS Lett., 1994, 342:109-114 .

Affiliated with

Also associated with

Rating

Antisense modulation of PI3 kinase p110 beta expression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense modulation of PI3 kinase p110 beta expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of PI3 kinase p110 beta expression will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-467430